Financing, Equity Capital Markets

Nurix Inc.

03/21
|
$160.4 Million
Piper Sandler served as bookrunner for Nurix Therapeutics Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma